Article info

Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health

Authors

  1. Correspondence to Doctor Antoine Vanier, Health Technology Assessment Department, Haute Autorité de Santé, La Plaine Saint-Denis, 93210, France; a.vanier{at}has-sante.fr
View Full Text

Citation

Vanier A, Fernandez J, Kelley S, et al
Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health

Publication history

  • Accepted January 19, 2023
  • First published February 14, 2023.
Online issue publication 
January 19, 2024

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.